NEW YORK (GenomeWeb) – Molecular diagnostics firm Empire Genomics today announced that it has received CE Marking for several of its products including fluorescent in situ hybridization probes and karyotyping media.
Landing the CE Mark "will please our world distributors and will go a long way in accelerating sales in Europe," Empire VP of International Business Development Reza Mazaheri said in a statement.
The firm said cytogenetic media, immunohistochemistry products, and fish probes were among the products to receive the CE Mark. Empire offers several molecular diagnostics products and services including FISH, genotyping, next-generation sequencing, and gene expression.
In January, Buffalo, New York-based Empire bought Canadian molecular diagnostics firm ID Labs.